Analysis: Kopran Limited

NSE:KOPRAN Pharma - API Market cap: ₹1.1K cr

Research report

companyname: Kopran Limited ticker: KOPRAN sector: Pharmaceuticals Kopran Limited is an integrated pharmaceutical company. It develops, manufactures and supplies Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). The company was established in 1958 and operates through two main business verticals. The formulations business runs through Kopran Limited itself. The API business runs through Kopran Research Laboratories Limited (KRLL), a wholly owned subsidiary. This struct...

Read the full report →
RS rating: 96 Stage: Stage 2

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Kopran Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.